Tuesday, July 8, 2025 7/8/2025

T32 Research Training Program in ImmunoEngineering

Award Number: T32EB021962
ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 09/01/2017
PERIOD OF PERFORMANCE END DATE: 05/31/2028

Group Awards By:

View Award Description

T32 Research Training Program in ImmunoEngineering - Abstract With the burgeoning of the fields of immunology and immunotherapy in the last few decades, the use of pharmaceutical products, biomedical devices, and biomaterials in immunological research and clinical applications has rapidly expanded. Accordingly, there has been an increasing need for engineers trained with the quantitative skills necessary for developing effective immunotherapies and translating these developments to industry. Immunology is a basic science that has a lot of applications that need to be translated to positively impact patients' lives. Most companies working in this area of ImmunoEngineering hire basic scientists since immunology is a basic science, albeit one that has a lot of applications amenable to translation in order to positively impact patients' lives (e.g. anti-inflammatory or immunosuppressive drugs, avoiding transplant rejection, adoptive cell therapy for cancer treatment). However, these individuals do not have training in engineering nor quantitative or systems perspectives. In contrast, engineers are also hired into companies that work in ImmunoEngineering areas, but often they do not have immunology training. The pre-doctoral training program described in this application is aimed to better equip engineers by training them in immunology (as well as in engineering). Funding for four trainees per year is requested for five years. Through this ImmunoEngineering training program, a new type of engineering doctoral trainee is being developed, one who can apply engineering principles with knowledge of immunology to make impacts on new treatments for disease and who will fill a critical gap in existing bioengineers entering today's work force. This training program will furthermore provide translational medicine and ethics training to equip trainees with important “soft skills” such as project and time management, ethics and understanding of the translational aspects of bring a product to market.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $217,824 )
2025	2025	GEORGIA TECH RESEARCH CORP	926 DALNEY ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	8	5/28/2025	NON-COMPETING CONTINUATION	$217,824
														Subtotal = $217,824

Issue Date FY: 2024 ( Subtotal = $212,534 )
2024	2024	GEORGIA TECH RESEARCH CORP	926 DALNEY ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	004	7	7/19/2024	NON-COMPETING CONTINUATION	$0
2024	2024	GEORGIA TECH RESEARCH CORP	926 DALNEY ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	003	7	7/12/2024	NON-COMPETING CONTINUATION	$212,534
2024	2023	GEORGIA TECH RESEARCH CORP	926 DALNEY ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	002	6	4/11/2024	COMPETING CONTINUATION	$0
2024	2023	GEORGIA TECH RESEARCH CORP	926 DALNEY ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	6	10/24/2023	COMPETING CONTINUATION	$39,582
2024	2021	GEORGIA TECH RESEARCH CORP	926 DALNEY ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	5	10/24/2023	NON-COMPETING CONTINUATION	-$39,582
														Subtotal = $212,534

Issue Date FY: 2023 ( Subtotal = $216,858 )
2023	2023	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	6	6/6/2023	COMPETING CONTINUATION	$216,858
2023	2021	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	5	5/29/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $216,858

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2021	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	5	10/19/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $164,583 )
2021	2021	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	5	9/21/2021	NON-COMPETING CONTINUATION	$199,695
2021	2020	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30332	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	4	6/9/2021	NON-COMPETING CONTINUATION	-$35,112
														Subtotal = $164,583

Issue Date FY: 2020 ( Subtotal = $199,467 )
2020	2020	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	4	9/16/2020	NON-COMPETING CONTINUATION	$197,466
2020	2019	GEORGIA TECH RESEARCH CORPORATION	926 DALNEY ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	3	12/16/2019	NON-COMPETING CONTINUATION	$2,001
														Subtotal = $199,467

Issue Date FY: 2019 ( Subtotal = $195,289 )
2019	2019	GEORGIA TECH RESEARCH CORPORATION	505 10TH ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	3	9/3/2019	NON-COMPETING CONTINUATION	$195,289
														Subtotal = $195,289

Issue Date FY: 2018 ( Subtotal = $239,430 )
2018	2018	GEORGIA TECH RESEARCH CORPORATION	505 10TH ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	2	8/22/2018	NON-COMPETING CONTINUATION	$191,544
2018	2018	GEORGIA TECH RESEARCH CORPORATION	505 10TH ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	2	9/18/2018	SUPPLEMENT FOR EXPANSION	$47,886
														Subtotal = $239,430

Issue Date FY: 2017 ( Subtotal = $191,090 )
2017	2017	GEORGIA TECH RESEARCH CORPORATION	505 10TH ST NW	ATLANTA	GA	30318	FULTON	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	1	8/9/2017	NEW	$191,090
														Subtotal = $191,090

Grand Total All Awards = $1,637,075

Top

All Categories

About

Search

Reports

Data Submission

Award Information

T32 Research Training Program in ImmunoEngineering

Award Number: T32EB021962

ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 09/01/2017

PERIOD OF PERFORMANCE END DATE: 05/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer